Groupe Kilani announces MSI 20000® certification for TERIAK

Groupe Kilani announces that TERIAK, its pharmaceutical subsidiary, has been awarded the MSI 20000® certification (Market Standard Indicator), presented at Euronext Paris by COFICERT under the auspices of the IGSF.

The certification ceremony gathered delegations from more than twenty countries, recognized for the quality of their financial governance.

MSI 20000® is an international standard assessing corporate financial soundness and performance. It stands as a recognized benchmark for governance and financial management best practices.

This recognition reflects Groupe Kilani's continued commitment to financial discipline and sound governance across all its business units.